Lupin's myotonia treatment drug gets European Commission's approval Posted By: Unknown January 08, 2019 Leave a Reply The approval makes NaMuscla the first treatment to be licensed throughout the EU for the symptomatic treatment of myotonia in adults with NOM disorders from Latest News http://bit.ly/2CUDgfA https://ift.tt/eA8V8J http://bit.ly/2SdCH5P Tweet Share Share Share Share
0 comments: